NEFL and Alzheimer disease: To validate whether plasma Aβ42, Aβ40, Aβ42/Aβ40, p-tau181, t-tau, and NfL levels can reflect CSF changes in AD, we performed a correlation analysis between plasma biomarkers and their CSF counterparts.